Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis

Area of Science:

• Genetics
• Immunology
• Vascular Biology

Background:

• Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting large arteries.
• Genetic factors are implicated in GCA pathogenesis, but specific gene associations remain under investigation.
• Endothelial nitric oxide synthase (eNOS) plays a crucial role in vascular homeostasis.

Purpose of the Study:

• To investigate the association between two polymorphisms in the eNOS gene (Glu/Asp(298) in exon 7 and 4a/b in intron 4) and susceptibility to GCA.
• To explore whether these eNOS polymorphisms correlate with the clinical presentation of GCA, particularly ischemic complications.
• To determine the role of eNOS gene variants in the development and manifestation of GCA.

Main Methods:

• Genotyping of 91 biopsy-proven GCA patients and 133 controls from Reggio Emilia, Italy, for eNOS polymorphisms.
• Utilizing polymerase chain reaction and allele-specific oligonucleotide techniques for genotyping.
• Stratifying GCA patients into subgroups based on the presence or absence of ischemic complications.

Main Results:

• The Glu/Asp(298) genotype distribution significantly differed between GCA patients and controls (P(corr) = 0.003).
• Carriers of the Asp(298) allele were significantly more prevalent in GCA patients (P(corr) = 0.0002, OR 3.3).
• No significant association was observed for the eNOS 4a/b polymorphism or between genotypes and ischemic complications in GCA patients.

Conclusions:

• The Glu/Asp(298) polymorphism in the eNOS gene is associated with an increased susceptibility to developing GCA.
• The findings suggest a genetic predisposition to GCA linked to this specific eNOS variant.
• Further research is needed to elucidate the precise mechanisms linking eNOS polymorphism to GCA pathogenesis.